TY - JOUR
AU - Zymliński, Robert
AB - Heart failure (HF) constitutes a significant clinical problem and is associated with a sizeable burden for the healthcare system. Numerous novel techniques, including device interventions, are investigated to improve clinical outcome. A review of the most notable currently studied devices targeting pathophysiological processes in HF was performed. Interventions regarding autonomic nervous system imbalance, i.e., baroreflex activation therapy; vagus, splanchnic and cardiopulmonary nerves modulation; respiratory disturbances, i.e., phrenic nerve stimulation and synchronized diaphragmatic therapy; decongestion management, i.e., the Reprieve system, transcatheter renal venous decongestion system, Doraya, preCardia, WhiteSwell and Aquapass, are presented. Each segment is divided into subsections: potential pathophysiological target, existing evidence and weaknesses or unexplained issues. Novel therapeutic devices represent great potential in HF therapy management; however, further evidence is necessary to fully evaluate their utility.
TI - Novel Therapeutic Devices in Heart Failure
JF - Journal of Clinical Medicine
DO - 10.3390/jcm11154303
DA - 2022-07-25
UR - https://www.deepdyve.com/lp/multidisciplinary-digital-publishing-institute/novel-therapeutic-devices-in-heart-failure-f09aRIXMc3
SP - 4303
VL - 11
IS - 15
DP - DeepDyve
ER -